Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2019 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (206)	10/11/2019 7:17:54 PM
From: rkrw	1 Recommendation Recommended By scaram(o)uche Read Replies (2) \| Respond to of 280

I've noticed how much faster you get the weekly updates out with Bulba in first place :)

To: BulbaMan who wrote (206)	10/13/2019 8:47:17 PM
From: andre_ybio	Read Replies (1) \| Respond to of 280

Happy Indigenous Peoples Day Bulba! Breaking news: Boycott Columbus Day (BCD) SF Charter files a petition to the Nobel award committee to nullify all awards since 1901 in Physics / Astronomy since discovering of new galaxies and planets is condescending to the Indigenous people who live there.

To: BulbaMan who wrote (206)	10/18/2019 5:01:03 PM
From: BulbaMan	1 Recommendation Recommended By rkrw Read Replies (1) \| Respond to of 280

10/18/2019 Contest update Biotech stocks and Contest portfolios, in particular, had a decent week for a change, nicely outperforming the broad market. At Friday’s close, the Contest median was up 6.57% YTD (vs. up 1.27% a week ago), the Nasdaq Biotech Index (NBI) was up 5.59% YTD (vs. up 3.51% a week ago) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 9.14% YTD (vs. up 6.96% a week ago), while the Nasdaq Composite Index (NCI) was up 21.92% YTD (vs. up 21.43% YTD a week ago). As is always the case for those who boast of “unmatched wisdom,” Bulba has been humbled. Assailed by short-sellers and jinxed by RKRW, Bulba’s portfolio is now in the sights of a pack of challengers. Although Bulba’s portfolio, up 63.23% YTD, remains in first place, its lead is clearly threatened. Closing in is OHMS’s portfolio which, electrified by buyout bid for ACHN, leaped into second place with a 59.37% YTD gain. Also a potential contender and moving into third place is HOOD’s portfolio, with a 53.12% YTD gain. At Friday's close, 27 of the 39 Contest portfolios were in the green, while 21 were beating the NBI and 16 were beating the SPSIBI. The 167 Contest stock picks have an average YTD gain of 10.18% and a median YTD loss of -5.14%. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None. (All corrections, especially adjustments for splits & mergers, greatly appreciated.) Enjoy a safe and relaxing fall weekend biotechies! Peace & good health, Bulba 10/18/19 Rank Name Profit/Loss 1 BULBA 63,229 2 OHMS 59,361 3 HOOD 53,120 4 ARTHUR 47,975 5 ANDRE 47,224 6 DEWO 46,631 7 KMASTR 41,565 8 LANCE 29,583 9 POMP 29,532 10 AJM 20,706 Week's Top 5 Gainers Symbol 10/11 10/18 Wk.%chg. RETA 95.810 184.910 93.00% ACHN 3.630 6.090 67.77% PLX 0.180 0.287 59.44% CNST 8.710 12.730 46.15% DMAC 1.840 2.620 42.39% Week's Worst 5 Losers Symbol 10/11 10/18 Wk.%chg. SYRS 8.790 6.740 -23.32% PBYI 7.130 6.500 -8.84% MRKR 4.560 4.160 -8.77% ADAP 1.060 0.969 -8.58% PTE 3.060 2.820 -7.84%